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PolycombRepressiveComplex 2 (PRC2) regulates key
developmental genes in embryonic stem (ES) cells and
during development. Here we show that Jarid2/
Jumonji, a protein enriched in pluripotent cells and
a founding member of the Jumonji C (JmjC) domain
protein family, is a PRC2 subunit in ES cells.
Genome-wide ChIP-seq analyses of Jarid2, Ezh2,
andSuz12 binding reveal that Jarid2 andPRC2 occupy
the samegenomic regions.Wefurther show thatJarid2
promotes PRC2 recruitment to the target genes while
inhibiting PRC2 histone methyltransferase activity,
suggesting that it acts as a ‘‘molecular rheostat’’ that
finely calibrates PRC2 functions at developmental
genes. Using Xenopus laevis as a model we demon-
strate that Jarid2 knockdown impairs the induction of
gastrulation genes in blastula embryos and results in
failureofdifferentiation.Ourfindings illuminateamech-
anism of histone methylation regulation in pluripotent
cells and during early cell-fate transitions.INTRODUCTION
Histonemethylationby thePRC2complex regulatesdevelopmental
gene expression patterns in multicellular organisms (Schuetten-
gruberetal., 2007;SimonandKingston,2009).PRC2contains three
core subunits: Ezh2, Suz12 and Eed, all of which are essential for
trimethylation of histone H3 lysine 27 (H3K27me3), a mark that
has been correlated with the silent state of target genes (Schuetten-
gruber et al., 2007; Simon and Kingston, 2009).
In ES cells PRC2 represses developmental genes involved in
cellular differentiation and organismal development (Boyer
et al., 2006; Lee et al., 2006). Deletion of any of the PRC2 core
components in mice results in gastrulation defects and early
embryonic lethality (Faust et al., 1998; O’Carroll et al., 2001;1290 Cell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc.Pasini et al., 2004). Nevertheless, mouse ES cells lacking Eed,
Suz12 or Ezh2 can be derived from the respective homozygous
knockout blastocysts and propagated in vitro (Morin-Kensicki
et al., 2001; Pasini et al., 2007; Shen et al., 2008). However,
loss of PRC2 function leads to defects in ES cell differentiation
(Chamberlain et al., 2008; Pasini et al., 2007; Shen et al.,
2008), emphasizing the essential role of PRC2 in executing
differentiation programs during early development.
Despite detailed molecular studies of the PRC2 components,
some outstanding questions remain largely unanswered: What
molecular mechanisms control PRC2 recruitment to the target
genes? What is the role of PRC2 in transitions from pluripotent
to restricted developmental fates? We used a combination
of biochemical, genomic and embryological approaches to
provide the first evidence that Jarid2/Jumonji (hereafter referred
to as Jarid2), a JmjC-domain protein enriched in pluripotent
cells, coordinates control of PRC2 occupancy and enzymatic
activity at target genes in ES cells and early embryos.
RESULTS
Jarid2 Associates with the PRC2 Complex in Mouse
ES Cells
To screen for novel PRC2 partners we immunopurified and
identified Eed-associated proteins using clonal mouse ES trans-
genic lines stably-expressing FLAG epitope-tagged Eed, as
diagrammed in Figure S1A, available online. In addition to previ-
ously characterized PRC2 components—Eed, Suz12, Ezh2 and
Aepb2—mass spectrometry analysis identified Jarid2 in Eed-
FLAG immunoprecipitates, but not control extracts (Figure 1A,
left panel; all identified peptides are listed in Table S1). Anti-
Jarid2 immunoblot analysis of Eed-FLAG eluates confirmed
association between Jarid2 and Eed (Figure 1B). To address
whether Jarid2 interacts with the intact PRC2 complex, we sub-
jected the Eed-FLAG eluate to another round of immunoaffinity
purification with anti-Jarid2 IgG or control IgG (Figure S1B).
Mass spectrometry analysis after this two-step purification iden-
tified all core PRC2 subunits in addition to Jarid2, indicating that
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Figure 1. Isolation of the PRC2 Complex
from ES Cells Identified Jarid2 as a Novel
Component
(A) Jarid2 associates with PRC2 in mouse ES
cells. Left panel: proteins specifically identified
in Eed-FLAG purification. Right panel: proteins
specifically identified in Eed-FLAG/Jarid2 double
purification. Protein identification scores (Mascot)
and numbers of tryptic peptides identified are
shown. See Figure S1 for purification schematics.
(B) Confirmation of Jarid2-Eed association. FLAG
immunoprecipitates from wt and Eed-FLAG ES
cells were analyzed by anti-Jarid2 immunoblotting.
(C) Association between endogenous Jarid2 and
PRC2. Endogenous Suz12, Ezh2, and Jarid2
proteins were immunoprecipitated from ES cell
nuclear extracts and analyzed by immunoblotting
with indicated antibodies.
(D) Jarid2 cosediments with PRC2. Eed-FLAG
eluates were separated on a 25%–50% glycerol
density gradient and fractions analyzed by immu-
noblotting with indicated antibodies.Jarid2 interacts with the intact PRC2 complex (Figure 1A, right
panel; peptides listed in Table S1).
Next, we showed that endogenous Suz12 and Ezh2 immuno-
precipitated endogenous Jarid2 from mouse ES cell nuclear
extracts and conversely, Jarid2 immunoprecipitated Suz12
and Ezh2 (Figure 1C). Furthermore, Jarid2 co-sedimented with
PRC2 in two high-density peaks in the glycerol-gradient sedi-
mentation analysis of the Eed-FLAG eluates (Figure 1D). Eed,
Suz12 and Ezh2 co-sedimented in fractions 3-5 in the absence
of Jarid2, suggesting that Jarid2 is not required for the assembly
of core PRC2 complex in mouse ES cells, consistent with
previous reports that the three core subunits—Eed, Ezh2, and
Suz12—form a stable complex (Cao and Zhang, 2004; Martin
et al., 2006). Nevertheless, the majority of PRC2 in ES cells
appears to be bound to Jarid2 (Figure 1D). Sedimentation anal-
yses of nuclear extracts from Jarid2 shRNA-expressing cells
(in which Jarid2 is downregulated to 30%–40% of wild-type
levels; described in detail below), revealed that the remaining
Jarid2 co-sediments with PRC2 in a single peak (Figure S1C).
These data suggest that the formation and/or stability of the
largest complex is sensitive to Jarid2 levels.
Numerousstudies demonstrated thatJarid2expression isunder
the control of ES transcriptional circuitry, including transcription
factors Nanog, Oct4, Sox2, Klf4 and Tcf3 (Boyer et al., 2005;
Cole et al., 2008; Kim et al., 2008; Loh et al., 2006; Zhou et al.,
2007). Jarid2mRNA is among the transcripts most highly enriched
in undifferentiated mouse and human ES cells and human oocytes
(Assou etal., 2009; Sun etal., 2008; Zhouetal., 2007). Interestingly,
due to conserved amino acid changes that preclude cofactor
binding (Figure S2A), Jarid2 lacks histone demethylase activity
characteristic of other JmjC domain proteins (Klose et al., 2006;
Lan et al., 2008; Shirato et al., 2009). We reasoned that Jarid2
represents an attractive candidate regulator of the PRC2 function.
A Short Motif Conserved in Jarid Proteins Is Required
for Interaction of Jarid2 and Jarid1a with Suz12
The mass spectrometry analysis of Jarid2 associated proteins
showed Suz12 as the most enriched PRC2 member (FigureC1A, right panel), suggesting a direct interaction. In agreement,
purified recombinant GST-Jarid2 recovered recombinant
Suz12 in a pull-down assay (Figure 2A, a and b). Two N-terminal
regions of Suz12 bound GST-Jarid2 (Figure 2A, c–f), and a single
Jarid2 region corresponding to amino acids 726-913 (fragment
d) was sufficient for binding to both Suz12 N-terminal fragments
(Figures 2B and 2C). In contrast, we failed to detect interaction of
Jarid2 with recombinant Ezh2, Eed, Aebp2 or RbAp48 (Figures
S2B and S2C).
Jarid2 is most closely related to the four Jarid1 family proteins,
which also contain JmjC domain and ARID (AT-rich interaction
domain) (Kortschak et al., 2000). Jarid1 proteins are active
H3K4me3 demethylases (Lan et al., 2008), and Jarid1a/Rbp2
was shown to associate with PRC2 (Pasini et al., 2008). Although
we failed to identify Jarid1a peptides in mass spectrometry anal-
ysis of Eed-FLAG eluates (Table S1), we detected Jarid1a-PRC2
association by coimmunoprecipitation and immunoblotting
(Figure S2D), and hypothesized that investigating the mode of
Jarid1 association with PRC2 may shed light on the molecular
recognition of PRC2 by Jarid proteins.
First, we tested whether Jarid1a, like Jarid2, binds Suz12.
Recombinant GST-fusion protein corresponding to amino acids
250-500 of human Jarid1a (fragment b) bound the second, but
not the first, N-terminal region of Suz12 (Figures 2D and 2E).
Thus, both Jarid2 and Jarid1a interact with Suz12 amino acid
region 185-370, but Jarid2 recognizes additional residues within
the first N-terminal fragment.
Jarid2 and Jarid1a regions responsible for Suz12 binding
do not overlap with any discernible structural domains (Fig-
ure 2F) and display low similarity, with the exception of a
highly homologous short sequence ‘‘GSGFP.’’ We hypothesized
that this motif may play a role in Suz12 recognition. Indeed,
mutations of GSGFP to GAGAA diminished binding of Jarid2
and Jarid1a fragments to full-length Suz12 (compare d and f in
Figure 2B, and b and e in Figure 2D). This motif is conserved in
all vertebrate Jarid2 proteins, as well as in C. elegans Jarid2
(Figure 2G), whereas D. melanogaster and other Drosophila
species contain a non-conservative substitution within the motifell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc. 1291
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Figure 2. Jarid2 and Jarid1a Directly Bind Suz12 via a Conserved Amino Acid Motif
(A) Recombinant Jarid2 associates with two N-terminal regions of Suz12. Full-length recombinant GST-Jarid2 protein (a) was used as a bait to pull full-length
Suz12-His (b), or Suz12-His protein fragments (c–f). Bound proteins were visualized by anti-His immunoblotting. In all experiments, ‘control’ represents gluta-
thione beads incubated with bacterial extracts not expressing bait proteins.
(B) Jarid2 region corresponding to aa 726–913 binds Suz12 in a ‘‘GSGFP’’ motif dependent manner. Recombinant GST-Jarid2 protein fragments were used to
pull recombinant full-length Suz12. Purified GST-fusion proteins were visualized by Coomasie staining (a-e, top panel, respective fusion proteins are marked with
asterisks), and Suz12 binding was assayed by anti-Suz12 immunoblotting (a–e, bottom panel). The ‘‘GSGFP’’ motif embedded in the fragment d (aa 726–913 of
mouse Jarid2), was substituted with ‘GAGAA’ sequence, and the mutated GST-fusion protein assayed for Suz12 binding (f).
(C) aa 726-913 fragment of Jarid2 is sufficient for binding to both N-terminal regions of Suz12. GST-Jarid2 aa 726-913 fusion protein (a) was used as a bait to pull
two N-terminal Suz12 fragments (aa 1-185 and aa 185-370 of mouse Suz12). Bound proteins were visualized by anti-His immunoblotting (b and c).
(D) Jarid1a region corresponding to aa 250-500 binds Suz12 in a ‘‘GSGFP’’ motif dependent manner. Recombinant GST-Jarid1a protein fragments were used to
pull full-length Suz12. Purified GST-fusion proteins were visualized by Coomasie staining (a–d, top panel, respective fusion proteins are marked with asterisks),
and Suz12 binding was assayed by anti-Suz12 immunoblotting (a–d, bottom panel). The GSGFP motif embedded in fragment b (aa 250–500 of mouse Jarid1a),
was substituted with GAGAA sequence, and the mutated GST-fusion protein assayed for Suz12 binding (e).
(E) aa 250-500 fragment of Jarid1a binds a single Suz12 N-terminal region, corresponding to aa 185-370. GST-Jarid1a (shown in a) was used to pull Suz12-His
fragments (b-e); bound proteins were visualized by anti-His immunoblotting.
(F) Schematic diagram summarizing binding results presented in (A)–(E).
(G) Conservation of the ‘GSGFP’ motif among Jarid proteins. Top panel: a sequence alignment of the ‘‘GSGFP’’-containing regions in Jarid2 proteins from indi-
cated species. Bottom panel: a sequence alignment of the ‘‘GSGFP’’-containing regions in the four M. musculus Jarid1 family members, and in D. melanogaster
Jarid1 homolog, Lid. Motif is highlighted in red.
(H) Jarid2 and Jarid1a protein levels in mouse ES cells. Immunoblot signals of endogenous Jarid2 or Jarid1a from a defined amount of ES nuclear extract were
compared to those of a serial dilution of purified, recombinant Jarid2 or Jarid1a protein fragments of a known concentration. Left and right panels represent same
exposure of the same blot. Estimated number of molecules per cell nucleus is shown at the bottom. Calculations can be found in Supplemental Experimental
Procedures.
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(GYGFP). The GSGFP motif is also conserved in all four Jarid1
family proteins: Jarid1a/RBP2, Jarid1b/PLU-1, Jarid1c/SMCX
and Jarid1d/SMCY, as well as in the single Jarid1 homolog
in Drosophila, Lid (Figure 2G). The presence of the GSGFP
motif in metazoan Jarid proteins suggests that the association
with Suz12 may be a common feature of Jarid family members.
However, we cannot exclude the possibility that additional
molecular interactions control Jarid-PRC2 complex formation
in vivo.
Mouse ES Cells Contain High Levels of Jarid2 Protein
The preferential recovery of Jarid2 in the Eed-FLAG purification
indicates that Jarid2 is the major Jarid family member associated
with PRC2 in ES cells. To estimate the relative molar amounts of
Jarid2 and Jarid1a proteins in ES nuclear extracts we compared
immunoblot signals of endogenous Jarid2 or Jarid1a to signals
from a serial dilution of purified, recombinant protein fragments
of known concentrations (Figure 2H). From this analysis we
calculated that 1 mg of ES nuclear extract contains 6 pmols of
Jarid2 and 0.12 pmole of Jarid1a. Although such measurements
are not precise, we further estimated that a single ES cell nucleus
contains about 50,000 Jarid2 and about 1000 Jarid1a molecules.
Interestingly, downregulation of Jarid2 results in a modest
upregulation of Jarid1a protein, but not RNA levels (Figures
S2E and S2F), perhaps via stabilization of Jarid1a through
PRC2 association.
Jarid2 Occupies PRC2 Targets Genome-Wide
To determine the genome-wide occupancy of Jarid2 in mouse
ES cells and to analyze the extent to which it overlaps with
PRC2 and Jarid1a binding, we used chromatin immunoprecip-
itation coupled with massively parallel DNA sequencing (ChIP-
seq; (Barski et al., 2007; Johnson et al., 2007). Illumina
Genome Analyzer was used to generate 13.5, 12.7, 18.7, 11,
and 28.5 million mapped sequence reads from Jarid2, Ezh2,
Suz12, Jarid1a, and control libraries, respectively. QuEST
ChIP-Seq analysis software (Valouev et al., 2008) identified
1337, 1692, 2073 and 1764 ‘‘significant regions’’ enriched
within Jarid2, Ezh2, Suz12 and Jarid1a ChIP-seq datasets [at
the false discovery rate (FDR) of less than 2.8%]. Significant
regions were identified for all proteins with high stringency
threshold of having at least one position with 50-fold or higher
enrichment.
Comparison of Jarid2, Suz12 and Ezh2 ChIP-Seq enrichment
signals revealed a nearly complete overlap of binding patterns
(as illustrated by the Hoxd gene cluster and Sox9 gene locus,
Figures 3A and S3A). We also observed good overlaps between
our binding data and those reported in the literature (Figures 3A
and S3A, compare top three panels with the panels displaying
Ezh2 data [Ku et al., 2008] and H3K27me3 data [Mikkelsen
et al., 2007]). However, we did not detect significant binding
of Jarid1a over PRC2 bound loci (Figures 3A and S3A). Next,
we analyzed genome-wide co-occupancy of the interrogated
proteins. Within Jarid2, Ezh2 and Jarid1a significant regions
(defined as having a peak of 50-fold or higher enrichment) we
identified relative fold enrichment of Suz12, Ezh2, Jarid2 and
Jarid1a (defined as the enrichment of sequence tags relative
to control across the entire region; less than 3-fold enrichmentCfalls within experimental variability and was considered as not
enriched). 99.2% and 99.8% of Jarid2 significant regions was
enriched for Suz12 and Ezh2, respectively, with the majority
of regions enriched over 10-fold (Figure 3B). Conversely,
99.7% and 99.7% of Ezh2 significant regions was enriched
for Suz12 and Jarid2, respectively. The majority of Ezh2 regions
were enriched for Jarid2 more than 10-fold (Figure 3B). Coloc-
alization of Jarid2 with PRC2 was also supported by high
correlation (0.66-0.89) of ChIP-seq binding signals among the
Jarid2, Ezh2 and Suz12 datasets (Figure 3C). There was also
good correlation of Jarid2 and Ezh2 binding with H3K27me3
(Figure 3B).
In sharp contrast, only 1% and 2% of Jarid2 and Ezh2 signif-
icant regions, respectively, was enriched for Jarid1a signals, and
none had over 10-fold enrichment (Figure 3B). Overall, Jarid1a
occupancy showed little correlation with PRC2 binding (0.18-
0.37, Figure S4A) or with enrichment for H3K27me3 (Figure 3B).
Instead, Jarid1a significant regions overlapped with H3K4me3
(Figure 3B and S3B).
Jarid2-PRC2 Targets Are Enriched for Unique DNA
Sequence Motifs
De novo search for motifs overrepresented within the Jarid2,
Ezh2 and Suz12 binding peaks identified two significant motifs
(Figure 3D) that were enriched at peaks and also throughout
the bound regions. The first motif is a tandem repeat of CCG
and is present within 61%–72% of Jarid2, Ezh2 and Suz12
regions (5% FDR). A second, GA-rich motif was present within
56%–66% of PRC2 and Jarid2 regions (5% FDR). Both motifs
were also significantly enriched within a previously reported
Ezh2 dataset from Ku et al. (2008) (60% and 57% of regions con-
tained these motifs, respectively).
Jarid2 and PRC2 Co-occupy Promoters of
Developmental Genes in Mouse and Human ES Cells
Jarid2 bound regions typically overlap with transcription start
sites (TSS; 69% overlap, Figure S5A) and exhibit a mean and
median size of 3.3 kb and 2.7 kb, respectively (Figure S5D).
Functional classification of identified targets via GO term anal-
ysis (Beissbarth and Speed, 2004) showed highly significant
enrichment in genes involved in development, morphogenesis,
and transcription (Figure S5B), similarly to what was previously
observed for PRC2 (Boyer et al., 2006). A complete list of Jarid2
bound genes is provided in Table S2.
To validate ChIP-seq results, we performed ChIP-qPCR anal-
yses of selected PRC2 target genes and, as a control, a gene not
bound by the PRC2 complex (Mcm6) using independently iso-
lated DNA from mouse and human ES cells. Relative Jarid2,
Ezh2 and Suz12 occupancy levels were correlated for all tested
PRC2 target genes in both mouse and human ES cells, indicating
that Jarid2 association with PRC2 targets is conserved between
mouse and human (Figures 4A and 4B).
To demonstrate that Jarid2 and PRC2 can simultaneously
bind to the same chromatin regions, we performed sequential
ChIP analysis. Chromatin from Eed-FLAG mouse ES cells was
first immunoprecipitated with FLAG antibody, followed by a
second ChIP step with either Jarid2, Suz12, or non-specific
IgG antibody. For all interrogated PRC2 targets, we detectedell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc. 1293
Figure 3. Jarid2 and PRC2 Occupy Same Genomic Targets in ES Cells
(A) Genome browser representation of Jarid2, Suz12, Ezh2, Jarid1a and H3K27me3 binding patterns at the Hoxd gene cluster in mouse ES cells. The top three
tracks represent calls for significantly enriched regions of Jarid2, Suz12 and Ezh2 ChIP-seq experiments as determined by QuEST software (Valouev et al., 2008).
Following are six tracks displaying calculated ChIP-Seq enrichment values across the locus for Jarid2, Suz12, Ezh2 from this study, Ezh2 (Ku et al., 2008), Jarid1a
from this study, and H3K27me3 (Mikkelsen et al., 2007) ChIP-seq datasets. Relative positions of genes and CpG islands are shown at the bottom.
(B) Comparisons of coenrichment between ChIP-seq experiments. The three bar graphs represent relative levels of enrichment (defined as the fold enrichment of
sequence tags relative to control across the entire region) of Suz12, Ezh2, Jarid2, Jarid1a, H3K27me3 and H3K4me3, as indicated, within Jarid2, Ezh2 and Jar-
id1a significant regions determined by QuEST. Three enriched categories correspond to ChIP-to-control tag enrichment ranges of 3-10 (orange), 10-30 (red) and
over 30 (purple). Non-enriched categories correspond to relative tag enrichment levels of 0-1 (blue) and 1-3 (green).
(C) Genome-wide analysis of Jarid2, Ezh2, and Suz12 co-occupancy. Scatter plots display mutual enrichment between indicated ChIP-Seq datasets relative to
the input. Correlation values are shown.
(D) Sequence motifs enriched in Jarid2-PRC2 bound regions. Logos (Crooks et al., 2004) for the two significant motifs identified using MEME software (from
200 bp windows around Jarid2 peaks) are shown. % of ChIP-seq regions containing the motif at 5% FDR is shown.simultaneous Jarid2 and PRC2 binding (Figure 4C). In sum,
biochemical association, direct binding between Jarid2 and
Suz12 in vitro, and target co-occupancy across the genome
strongly suggest Jarid2 is an integral PRC2 subunit in ES cells.1294 Cell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc.Jarid1a/Rbp2 Occupies Promoters of Genes Involved
in RNA Metabolism and Mitochondrial Function
Although we identified 1764 genomic regions enriched for
Jarid1a, we failed to detect an overlap with PRC2 binding.
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Figure 4. Jarid2 and PRC2 Simultaneously Bind Target Genes
(A) ChIP-qPCR analyses of Jarid2, Ezh2 and Suz12 binding at selected target
genes in mouse ES cells.
(B) ChIP-qPCR analyses of JARID2, EZH2 and SUZ12 binding at selected
target genes in human ES cells.
(C) Sequential ChIP of Suz12 and Jarid2 from Eed-FLAG-bound chromatin.
y axis shows percent of input recovery. Error bars represent standard deviation
calculated from triplicate qPCR reactions. Findings were confirmed by multiple
biological replicates.Consistently, functional classification of identified Jarid1a
targets showed enrichment of genes involved in RNA processing
and mitochondrial function, but not in development (Figure S5C).
82% of Jarid1a significant regions overlapped with H3K4me3
(representing 15% of all H3K4me3 significant regions in mouse
ES cells). These targets were not bivalently marked, however,
as we failed to detect an overlap between Jarid1a and
H3K27me3 (Figure 3B). We also noted a quantitative difference
in the size of Jarid1a and Jarid2 bound regions (Figure S5D).
De novo motif search analysis revealed enrichment for
a consensus recognition site of the Ets family transcription factor
GABP in 55% of Jarid1a bound regions (Figure S4B). Intriguingly,
our observations parallel those made in a previous ChIP-chip
study of JARID1A occupancy in human promonocytic U937 cells
(Lopez-Bigas et al., 2008). These parallels include: (i) overrepre-
sentation of RNA metabolism and mitochondrial gene targets, (ii)
enrichment for Ets family binding sites, and (iii) strong overlapCwith H3K4me3 in the absence of H3K27me3. Strikingly, 79%
(185 out of 232) of JARID1A targets reported by Lopez-Bigas
et al. (2008) in U937 cells are found in our Jarid1a dataset,
despite differences in cell type, species and antibody used in
the two studies. The findings outlined above suggest that a signif-
icant subset of Jarid1a targets represents house-keeping genes
active across many cell types in humans and mice.
To confirm that our results are not an artifact of antibody cross-
reactivity, we performed ChIP-qPCR analyses using five different
anti-Jarid1a antibodies. We failed to detect Jarid1a binding to
PRC2 targets with any of the antibodies (Figure S6A), but
observed Jarid1a enrichment at all interrogated Jarid1a target
genes identified by ChIP-seq with all tested antibodies (Fig-
ure S6B). Taken altogether, our data strongly argue that Jarid2,
not Jarid1a, is the major PRC2 partner at chromatin targets in
ES cells. We therefore focused our subsequent analyses on the
mechanisms by which Jarid2 regulates PRC2 functions.
Jarid2 Is Important for Recruitment and/or Stabilization
of PRC2 at Target Genes
To address whether Jarid2 downregulation affects PRC2 target
occupancy we developed stable, clonal mouse ES cell lines
expressing shRNA targeting Jarid2 or, as a control, a non-target-
ing shRNA, in a doxycycline (Dox) inducible manner. Dox treat-
ment of Jarid2 shRNA cells resulted in Jarid2 downregulation
to 30%–40% of control levels (Figure S7A), without affecting
total Ezh2 and Suz12 protein levels (Figure S7A), Oct4 expres-
sion (Figure 5D), or ES cell proliferation (data not shown). ChIP-
qPCR analysis showed varied Jarid2 levels at different targets,
nevertheless in all cases both Jarid2 and Ezh2 occupancy
were significantly reduced upon Jarid2 knockdown (Figure 5A).
To exclude a possibility that diminished PRC2 binding is an
artifact of shRNA off-target effects, we used the heterozygous
Jarid2 gene trap mouse ES line (Davisson, 2006) to assay Jarid2
and Ezh2 protein levels and target occupancy. As this line was
developed in a different genetic background than the one used
throughout this study (E14 versus LF2), we compared wt LF2
cells, wt E14 cells and Jarid2 -/+ E14 (CSA 131) cells. Total
levels of Jarid2 protein were higher in LF2 as compared to
E14 cells, and were further diminished in Jarid2 -/+ E14 cells
(Figure S7B). Nevertheless, Jarid2 target occupancy was com-
parable between LF2 and E14 wt cells, with reduced binding in
Jarid2 -/+ E14 cells (Figure 5B), indicating that even a modest
two-fold reduction of Jarid2 levels is sufficient to diminish Ezh2
association with target genes.
Jarid2 and PRC2 Association with Target Genes Is
Mutually Dependent
If Jarid2 and PRC2 cooperate in target recognition, then Jarid2
chromatin binding should be PRC2-dependent. To test this
prediction, we assayed occupancy of Ezh2, Suz12 and Jarid2
at selected target genes in Eed / ES cells. Consistent with
Eed serving as a linchpin for the PRC2 complex, Suz12 and
Ezh2 binding was diminished in Eed/ as compared to wt cells
(Figure 5C). Jarid2 binding was concomitantly reduced, indi-
cating that Jarid2 and PRC2 target association is mutually
dependent (Figure 5C). However, we observed a two-fold down-
regulation of Jarid2 protein levels in Eed / cells (Figure S7C),ell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc. 1295
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Figure 5. Jarid2 Controls PRC2 Target Occupancy in ES Cells
(A) Knockdown of Jarid2 results in diminished Ezh2 target binding. ChIP-qPCR analyses of Jarid2 and Ezh2 occupancy at selected target genes in clonal mouse
ES cell lines expressing shRNA targeting Jarid2 (Jarid2 shRNA cl.1 and 2) versus non-silencing shRNA. y axis shows percent of input recovery.
(B) Ezh2 association with gene targets is decreased in Jarid2 -/+ ES cells. ChIP-qPCR analyses are of wt LF2, wt E14, and E14 Jarid2 -/+ mouse ES cell lines.
(C) Jarid2 and PRC2 target occupancy is mutually dependent. ChIP-qPCR analyses of Suz12, Ezh2 and Jarid2 occupancy at selected target genes in wt and
Eed / mouse ES cells.
(D) Jarid2 regulates expression of PRC2 target genes. RT-qPCR analysis of mRNA levels in Jarid2 shRNA cl.1 and 2 and non-silencing shRNA mouse ES cell lines.
Expression was normalized to Pdha1 mRNA levels.
(E) Expression of PRC2 targets is upregulated in Jarid2 -/+ ES cells. RT-qPCR analysis of mRNA levels (normalized to Pdha1), in wt LF2, wt E14, and E14
Jarid2 -/+ mouse ES cell lines.
Error bars represent standard deviation calculated from triplicate qPCR reactions.which may in part account for the diminished association of
Jarid2 with targets.
Jarid2 Knockdown Results in Derepression of PRC2
Target Genes in ES Cells
Loss of PRC2 components in ES cells results in upregulation
of PRC2 target genes (Boyer et al., 2006; Pasini et al., 2007).1296 Cell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc.To test whether Jarid2 knockdown leads to a similar effect,
we assayed mRNA expression levels of selected PRC2 target
genes in ES cell lines expressing Jarid2 or non-silencing
shRNAs. Whereas Oct4 mRNA levels were comparable among
all shRNA lines, expression of interrogated PRC2 target genes
was upregulated upon Jarid2 knockdown (Figure 5D). Similarly,
expression of PRC2 target genes was also upregulated in
Figure 6. Jarid2 Directly Inhibits PRC2 Histone Methyltransferase Activity
(A) Jarid2 inhibits PRC2 HMT activity on core histones. Purified reconstituted PRC2 complex was pre-bound to 0, 0.1, and 0.2 ug of purified recombinant Jarid2
and used in HMT assays with native HeLa core histones as substrates and tritium-labeled S-adenosyl-methionine (3H-SAM) as a cofactor. 3H-methyl incorpo-
ration was visualized by fluorography (top panel). Histones, Jarid2 and Ezh2 present in each reaction were visualized by Coomasie staining, allowing for direct
comparisons of the relative protein levels (bottom panels).
(B) Jarid2 inhibits PRC2 HMT activity on nucleosomes. Reactions were performed as in (A) except that in vitro assembled recombinant nucleosomal templates
were used as substrates.
(C) H3K27me3 levels at selected PRC2 target genes are not significantly affected by Jarid2 knockdown. ChIP-qPCR analysis of H3K27me3 levels in mouse ES
line expressing Jarid2 shRNA (Jarid2 shRNA cl. 2) versus non-silencing shRNA. We verified that histone recognition by H3K27me3 antibody is PRC2 dependent
(Figure S8E).
(D) H3K4me3 levels at selected PRC2 target genes in Jarid2 shRNA ES cells. ChIP-qPCR analysis of H3K4me3 levels in clonal mouse ES line expressing Jarid2
shRNA (Jarid2 shRNA cl. 2) versus non-silencing shRNA.
(E) Model of Jarid2 in modulation of PRC2 recruitment and enzymatic activity. In ES cells, Jarid2 gene is under control of ES regulatory circuitry, resulting in high
levels of Jarid2 expression and preferential formation of Jarid2-PRC2 complexes. Jarid2 simultaneously promotes the recruitment and inhibits the enzymatic
activity of PRC2 (indicated as a balance). PRC2 targeting is mediated via a combinatorial mechanism involving Jarid2, other proteins and non-coding RNAs.Jarid2 -/+ E14 cells, as compared to wt E14 and LF2 ES lines
(Figure 5E).
Jarid2 Negatively Regulates PRC2 Enzymatic Activity
To test whether, in addition to targeting, Jarid2 can also regulate
PRC2 enzymatic activity, we performed histone methyltransferase
(HMT) assays with purified reconstituted recombinant PRC2
complex either in the absence or in the presence of the
recombinant full-lengthJarid2,andusingnativecoreHeLahistones
as a substrate. Addition of sub-stoichiometric amounts of Jarid2
was sufficient to inhibit PRC2 HMT activity in a dose-dependent
manner (Figure 6A), while addition of other recombinant chromatin
proteinshad no effect (Figure S8A). Similarly, Jarid2 inhibited PRC2
HMT activity on nucleosomal substrates (Figure 6B). However,Caddition of Jarid2 to H3K4 methyltransferase complexes purified
via the Ash2 core subunit had no effect on its HMT activity
(Figure S8B). Moreover, Jarid2 stimulated HMT activity of recombi-
nant, purifiedH3K9methyltransferaseG9a (FigureS8C),whichwas
previously shown to bind Jarid2 (Shirato et al., 2009). In sum, these
results demonstrate that Jarid2 specifically inhibits PRC2 HMT
activity in vitro and suggest that it plays diverse roles in regulation
of histone methyltransferases in distinct cellular contexts. As
HMT assays were performed in the absence of cofactors other
than S-adenosyl-methionine (SAM), Jarid2-mediated inhibition of
PRC2 HMT likely occurs through a nonenzymatic mechanism.
Interestingly, we found that recombinant Jarid1a also inhibited
PRC2 HMT activity in vitro (Figure S8D), indicating that other Jarid
family members may regulate PRC2 enzymatic function.ell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc. 1297
Next, we studied the effects of Jarid2 downregulation on
H3K27me3 levels in vivo. Although a modest reduction of Jarid2
levels achieved in our ES lines is sufficient to reduce Ezh2
target occupancy by 2-6 fold (Figure 5A), we observed little to
no effect on H3K27me3 levels at the same gene targets
(Figure 6C). For example, the Sox9 gene exhibited the strongest
relative downregulation of Ezh2 occupancy, yet a slight upregu-
lation of H3K27me3 levels (Figure 6C), suggesting that the
Jarid2-containing PRC2 complex is less active. Interestingly,
despite unaffected H3K27me3 levels, expression of PRC2 target
genes was upregulated upon Jarid2 knockdown (Figure 5D), and
this upregulation correlated with a modest increase in H3K4me3
levels (Figure 6D). Our results demonstrate that Jarid2 negatively
regulates PRC2 HMT activity.
Jarid2 Depletion Results in Gastrulation Defects
in Xenopus Embryos
Jarid2 promotes PRC2 recruitment to the target genes while
inhibiting PRC2 enzymatic activity, suggesting that it modulates
PRC2 function at developmental genes, perhaps to sensitize
them for subsequent activation during differentiation (Figure 6E).
To address whether Jarid2 is important for gene regulation
during early embryogenesis, we downregulated Jarid2 levels in
Xenopus laevis embryos by injecting morpholino oligonucleo-
tides targeting the translation start sites of both non-allelic
copies of X. laevis Jarid2 (Jarid2 MO1). Jarid2 amino acid
sequence and domain composition is highly conserved between
frogs and mammals (Figure S9).
Immunoblot analysis of embryonic extracts showed that
Jarid2 MO1 injection resulted in the downregulation of Jarid2,
without affecting Suz12 protein levels (Figure 7A). Jarid2 MO1
injected embryos exhibited gastrulation arrest, whereas control
embryos proceeded to develop normally and were assayed
at the neurula stage (Figure 7B; phenotype penetrance in
Figure 7C). To ensure that the observed phenotype does not
result from off-target effects, we designed two additional
translation-blocking MOs, each matching one of the two non-
allelic Jarid2 copies (Jarid2 MO2a and Jarid2 MO2b). Injection
of either of the MOs resulted in phenocopy of Jarid2 MO1
phenotype. When co-injected together in equimolar amounts
(referred to as Jarid2 MO2) at 2-4 fold lower concentration
than either Jarid2 MO1, Jarid2 MO2a, or Jarid2 MO2b alone,
these two MOs showed a strong synergistic effect resulting in
100% penetrant developmental arrest at the late blastula stage
(Figure 7B; quantified in Figure 7C, protein knockdown verified
in Figure S10A). Injection of Suz12 MO also resulted in arrest
prior to completion of gastrulation (Figure 7B and C), consistent
with gastrulation defects reported in Suz12 / mice (Pasini
et al., 2004). In contrast, injection of MOs targeting H3K4
methyltransferase MLL1 or Jarid1a had no effects on gastrula-
tion (not shown).
Jarid2 Is Required for Activation of Gastrulation Gene
Expression Program
In Xenopus embryos, genes necessary for orchestrating gastru-
lation events are induced during the mid- and late blastula stage.
The late blastula stage corresponds to the critical transition
period during which cells exit pluripotency and restrict their1298 Cell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc.developmental potential, but have not yet differentiated to form
three germ layers. In agreement with a recent report (Akkers
et al., 2009), H3K27me3 levels at selected early differentiation
genes significantly increased during the transition from mid- to
late blastula stage (Figure S10B and C, compare % input
recovery scales on y axis in B and C). Importantly, Jarid2 knock-
down resulted in further upregulation of H3K27me3, evident
particularly at the late blastula stage (Figure 10B and C) and
consistent with repression of PRC2 HMT activity by Jarid2.
To assay the effects of Jarid2 downregulation on gene expres-
sion, we performed quantitative RT-qPCR analyses from late
blastula stage embryos, either untreated or injected with Jarid2
MO1, Jarid2 MO2 or Suz12 MO. Expression of genes involved
in germ layer formation was downregulated by all assayed
MOs (Figure 7D), although generally Jarid2 MOs displayed
a more prominent effect than Suz12 MO. In contrast, analysis
of a cohort of non-developmental genes revealed no significant
effect on expression (Figure 7D), indicating that MO treatment
did not cause a global transcriptional failure. Furthermore,
whole-mount RNA in situ hybridization analysis of gastrula
embryos asymmetrically injected with Jarid2 MO1 at the two-
cell stage (resulting in Jarid2 depletion in half of the embryo)
revealed diminished expression of gastrulation genesBrachyury,
Wnt8 and Xnot on the MO-injected side of the embryo (Fig-
ure 7E). In sum, our observations indicate that Jarid2 function
is essential for induction of gastrulation programs at the exit
from pluripotency.
Jarid2 Knockdown Results in Failure to Induce
Mesoderm in Response to Activin Signaling
Xenopus ectodermal explants isolated from blastula stage
embryos can be induced in vitro to form mesoderm by treatment
with Activin, a ligand for Nodal signaling, but the competence to
induce mesoderm is lost by the end of gastrulation (Kimelman,
2006).
To test whether Jarid2 depletion affects induction of meso-
dermal genes or, alternatively, results in the delayed or pro-
longed competence for induction, we isolated ectodermal
explants from the early blastula stage control or Jarid2 MO-
treated embryos, cultured them either in the absence of Activin
or in the presence of Activin pulse at blastula, early gastrula or
late gastrula stages, respectively, and analyzed gene expression
by RT-qPCR (Figure 7F). Control explants not exposed to Activin
established a default epidermal fate, as evidenced by the
expression of epidermal Keratin. Activin treatment of control
explants at blastula stages resulted in the induction of the
mesodermal markers XHex and GATA6 and suppression of the
default epidermal fate, whereas treatment at early gastrula
stages lead to the induction of cardiac and muscle actin, again
accompanied by the suppression of the epidermal fate (Fig-
ure 7G). The competence for mesoderm induction was lost by
late gastrula stages.
In contrast, Jarid2 depleted embryos failed to induce meso-
dermal markers in response to Activin treatment at any of the
assayed stages, suggesting a differentiation defect rather than
altered timing of developmental competence. Remarkably,
Jarid2 depleted explants also failed to realize their default devel-
opmental potential as evidenced by the absence of epidermal
Figure 7. Jarid2 Is Required for Induction of
Gastrulation Programs in Xenopus Embryos
(A) Knockdown of Jarid2 protein in Xenopus embryos.
Immunoblotting analysis of nuclear extracts from gastrula
stage embryos derived from control or Jarid2 MO1-
injected two-cell stage embryos.
(B) Downregulation of Jarid2 or Suz12 results in gastrula-
tion arrest. Representative images of control, Jarid2
MO1-, Jarid2 MO2-, and Suz12 MO- treated embryos
developed from the same batch of zygotes. Control
embryos completed gastrulation and proceeded to neuru-
late (imaged at stage 13), whereas Jarid2 MO1, Jarid2
MO2, and Suz12 MO embryos arrested at the late blastula
stage or during early gastrulation (stages 9-10.5).
(C) Penetrance of gastrulation defects shown in (B).
(D) Impaired induction of gastrulation genes in Jarid2
MO1, Jarid2 MO2, and Suz12 MO embryos. RT-qPCR
analyses of mRNA levels in control (C), Jarid2 MO1-
treated (J1), Jarid2 MO2-treated (J2) and Suz12 MO-
treated (S) late blastula stage embryos. mRNA levels of
selected gastrulation genes (top panel) and housekeeping
genes (bottom panel) are shown.
(E) Jarid2 knockdown perturbs germ layer formation.
Whole mount in situ detection of Xbra, Xnot, and Wnt8A
transcripts in gastrula stage embryos derived from control
or embryos asymmetrically injected with Jarid2 MO1 into
one blastomere at the two-cell stage.
(F) Schematic diagram of ectodermal explant assay. Ecto-
dermal explants were isolated from the animal poles of
early blastula embyos (stage 7) and cultured in the
absence (‘‘U’’) or in presence of Activin A during: blastula
stages 8 and 9 (‘‘8’’), early gastrulation between stages
10 and 11 (‘‘10’’), or late gastrulation between stages 11
and 12 (‘‘11’’). At developmental stage 15, explants were
harvested for quantitative RT-qPCR assay.
(G) Impaired mesoderm induction in response to Activin in
Jarid2 MO explants. Results of RT-qPCR gene expression
analysis of indicated genes relative to the whole sibling
embryo at the same stage. Blue and red boxes indicate
control and Jarid2 MO treated explants, respectively.
In panels D and G the central line of the box and whisker
plot represent median value, the hinges approximate
quartiles and the whiskers extremal values (minimum
and maximum).Keratin expression (Figure 7G), indicating that Jarid2 depletion
results in differentiation failure.
DISCUSSION
The work presented here provides important insights into the
regulation of PRC2 recruitment and activity in ES cells and early
embryos, illuminates a novel mechanism of histone methylation
regulation by Jarid proteins and suggests that JmjC domain
proteins exhibit important, but previously unappreciated func-
tions outside of their activities as histone demethylases.
Jarid2 Function in PRC2 Targeting
Jarid2 contains a DNA-binding ARID domain and was shown to
associate with DNA-binding proteins (Kim et al., 2004), suggest-Cing a role for Jarid2-mediated DNA recognition in PRC2 recruit-
ment. Our de novo sequence motif analysis identified a CCG-
repeat motif as highly overrepresented among Jarid2-PRC2
targets. Interestingly, the ARID domain of another Jarid family
member preferentially binds CCG-rich DNA (Tu et al., 2008).
Perhaps the ARID domain of Jarid2 exhibits similar specificity
and accounts for the previously reported preferential association
of PRC2 with CpG-island rich promoters (Ku et al., 2008).
Alternative to a direct role in DNA binding, Jarid2 may coordi-
nate assembly of the higher order PRC2 complex, competent
for proper targeting. Regardless of the exact mechanism, we
favor the view that in vertebrate organisms the nature of PRC2
recruitment is combinatorial and tissue-specific, with PRC2
complex subunits and/or additional PRC2-associated protein
and RNA cofactors cooperate with Jarid2 in ES cells and earlyell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc. 1299
embryos (Figure 6E). For example, a PRC2 subunit Aebp2, YY1
and long non-coding RNAs have all been suggested to
contribute to PRC2 targeting in mammalian cells (Kim et al.,
2009; Simon and Kingston, 2009).
Jarid2 Coordinates Regulation of PRC2 Recruitment
and Enzymatic Activity
Although Jarid2 promotes PRC2 targeting and its binding is
tightly correlated with H3K27me3 distribution genome-wide,
counter-intuitively, Jarid2 represses PRC2 enzymatic activity.
Perhaps such fine calibration of PRC2 functions is necessary
to maintain a repressed, yet poised state of developmental
genes and to permit subsequent gene activation during differen-
tiation. Indeed, depletion of Jarid2 in early Xenopus embryos
results in failure of differentiation and developmental gene induc-
tion, concomitant with accumulation of H3K27me3.
A modest downregulation of Jarid2 in ES cells is sufficient to
diminish PRC2 target gene occupancy, leading to derepression
of PRC2 target genes, despite relatively unaffected H3K27me3
levels. This observation suggests that the Jarid2-PRC2 com-
plex can silence gene expression in part independently of
H3K27me3.
Jarid Family Proteins as PRC2 Modulators
Both Jarid2 and Jarid1a directly inhibit PRC2 HMT activity in vitro
in the absence of cofactors other than SAM, and in particular in
the absence of cofactors required for histone demethylation,
implying a nonenzymatic mechanism of inhibition. Intriguingly,
Jarid1a, an active H3K4me3 demethylase (Christensen et al.,
2007; Klose et al., 2007), binds genomic regions enriched for
H3K4me3. Thus, perhaps in certain biological contexts Jarid1a
regulates both H3K4 and H3K27 methylation levels, albeit via
distinct molecular mechanisms.
The conservation of Suz12 binding motif suggests that associ-
ation with PRC2 is a common feature of Jarid family proteins. In
ES cells, where the Jarid2 gene is under control of the pluripo-
tency circuitry and approximately 50,000 Jarid2 molecules are
present in the nucleus of each cell, the complex formation equi-
librium is shifted toward Jarid2-PRC2 (Figure 6E). Nevertheless,
the observation that Jarid1a and Jarid2-PRC2 exhibit virtually
non-overlapping genomic binding patterns indicates that addi-
tional mechanisms beyond Suz12 recognition must regulate
target specificity of Jarid-PRC2 complexes.
Jarid2 Is a Key Regulator of Vertebrate Development
Jarid2 is important for proper organogenesis of tissues derived
from all three germ layers, including brain, heart and liver
[reviewed in (Takeuchi et al., 2006)]. Jarid2 gene trap homozy-
gous mice gastrulate normally but show defects in neural plate
formation and neural tube closure (Takeuchi et al., 1995), result-
ing in the cruciform-like structure (hence the name ‘‘Jumonji,’’
Japanese for cruciform). Although these observations under-
score a critical role of Jarid2 in development, they differ from
our observation that Jarid2 is essential for gastrulation in Xeno-
pus. The discrepancy may be explained in several ways: (i)
gene trap embryos partially retain Jarid2 function, (ii) maternal
Jarid2 transcripts provide a significant contribution (translation
of frog maternal transcripts is blocked by MO injection), (iii) other1300 Cell 139, 1290–1302, December 24, 2009 ª2009 Elsevier Inc.Jarid proteins complement Jarid2 more efficiently in mice, (iv)
Jarid2 is not important for early development in mice. Although
at present we cannot distinguish among the aforementioned
possibilities, the last scenario is unlikely: regulation of Jarid2
transcription by multiple components of ES transcriptional
circuitry in mice and humans indicate that an evolutionary pres-
sure existed in mammals to preserve Jarid2 function in the early
embryo. Moreover, Jarid2 downregulation affects the induction
of differentiation genes during embryoid body formation from
mouse ES cells (J.P. and J.W., unpublished data).
The Role of Jarid2-PRC2 during the Transition
from Pluripotent to Restricted Cell Fates
Elegant transplantation experiments demonstrated that cells of
early blastula stage Xenopus embryos remain pluripotent (Heas-
man et al., 1984; Snape et al., 1987). This multilineage differenti-
ation potential becomes gradually restricted in late blastula
embryos when cells exit pluripotency, culminating in the first
differentiation events during gastrulation (Heasman et al., 1984;
Snape et al., 1987).
We demonstrated that H3K27me3 levels at developmental
genes in X. laevis embryos increase by an order of magnitude
just prior to the onset of gastrulation; this temporal regulation
of H3K27me3 was also reported in X. tropicalis (Akkers et al.,
2009). Jarid2 depletion results in a further aberrant increase of
H3K27me3 levels, concomitant with the failure of developmental
gene induction in the late blastula embryos. Thus, Jarid2-medi-
ated modulation of PRC2 activity at the exit from pluripotency
appears critical for the subsequent execution of developmental
programs.
EXPERIMENTAL PROCEDURES
Antibodies
Antibodies used in this study are listed in Table S4.
cDNAs
Primers used for cloning are described in Table S7.
Cell Lines
Please see Supplemental Experimental Procedures.
Protein Extraction and Immunoprecipitation
Nuclear extracts were prepared from ES cells according to the Dignam
protocol (Dignam et al., 1983). For FLAG IP, nuclear extracts were incubated
with M2 FLAG agarose (Sigma), beads were washed and eluted with
0.25mg/ml 3xFLAG peptides (Sigma) in PBS 0.2% Triton X-100.
Glycerol Gradients
4.5 ml 25%–50% glycerol density gradient was prepared using a Hoefer SG15
gradient maker. Eed-FLAG eluates were laid on top of each gradient and
separated by 40,000 RPM centrifugation for 3 hr in a SW50.1 rotor (Beckman);
180 ul fractions were collected.
HPLC/MS/MS Analysis
HPLC/MS/MS analysis was performed with the Agilent 1100 nanoflow liquid
chromatography system and a LTQ two-dimensional ion trap mass spectrom-
eter equipped with a nanoelectrospray ionization source. Database search
was conducted with Mascot 2.1 and the NCBI nr database. Details can be
found in the Supplemental Experimental Procedures.
Chromatin Immunoprecipitation, ChIP-qPCR, and ChIP-seq Library
Preparation
ChIP from ES cells and Xenopus embryos was performed according to
Boyer et al. (2005) and Blythe et al. (Blythe et al., 2009), respectively, using
100–500 ug of chromatin per IP. ChIP-qPCR signals were calculated as %
of input. Primer sequences are included in Table S5. For sequential ChIP,
8 mg of chromatin prepared from Eed-FLAG cells were incubated with M2
agarose, and Eed-FLAG chromatin was eluted with 3XFLAG peptide. The
eluted Eed-FLAG chromatin was subsequently immunoprecipitated with
Suz12 and Jarid2 antibodies using the standard ChIP protocol. ChIP-seq
libraries were prepared according to Illumina protocol and sequenced using
Illumina Genome Analyzer; 26–36 base-pair-long reads were obtained.
ChIP-seq Data Analysis
All sequences (including those from Ku et al., 2008 and Mikkelsen et al., 2007)
were mapped by ELAND software (Illumina Inc) and analyzed by QuEST 2.4
software (Valouev et al., 2008) using a ‘‘histone’’ or ‘‘punctate binding site’’
setting (bandwidth of 100 bp, region size of 1000 bp) and default stringency
(corresponding to 50-fold ChIP to input enrichment for seeding the regions,
and 3-fold ChIP enrichment for extending the regions).
ChIP-seq Data Availability
All ChIP-Seq datasets have been deposited into GEO repository (GSE18776).
shRNA Lentivirus Infection and Selection
The Jarid2 shRNAmir construct was purchased from Open Biosystems (Cat
#:RMM4431-98858628) and subcloned into the pTRIPZ Tet-on inducible
vector. Verified nonsilencing shRNA (RHS4335) were purchased from Open
Biosystems. VSVG pseudotyped lentiviruses were produced in 293T cells
using standard procedure. Selection was done by 1.5ug/ml puromycin for
2 weeks and clones screened by RFP expression after 4-day doxycyclin
(1ug/ml) induction.
Morpholino Design
Translation-blocking morpholinos designed to Xenopus laevis Jarid2 (Jarid2
MO1 50 TCCTCTTGGGCCTTTCCTTGCTCAT 30; Jarid2 MO2a 50 GGCCTTTC
CTTGCTCATCCTGTTAT 30 and Jarid2 MO2b 50 GGCCTTTCCTTGCTCAT
CCTGTTCT 30) and Suz12 (Suz12 MO 50 CCATGCGGGATACTACGAGTGA
TAA 30) were obtained from Gene Tools LLC (http://www.gene-tools.com)
and resuspended at 1mM.
Additional details can be found in the Supplemental Experimental
Procedures.SUPPLEMENTAL DATA
Supplemental Data include ten figures, seven tables, Supplemental Experi-
mental Procedures, and Supplemental References and can be found with this
article online at http://www.cell.com/supplemental/S0092-8674(09)01506-2.
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